Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ:IMRN)

2.190 -0.010 (-0.45%)
Streaming Delayed Price Updated: 1:03 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target
New York, New York--(Newsfile Corp. - October 17, 2025) - Emerging Growth Research today announced the initiation of coverage on... 
Via Newsfile
Immuron Q1 FY26 YoY growth
From Immuron Limited
Via GlobeNewswire
Immuron Submits IMM-529 IND to FDA
From Immuron Limited
Via GlobeNewswire
Immuron Stock Rallies After CEO Dismisses US Pharma Tariff Impact, Provides Positive Pipeline Updates
CEO Steven Lydeamore stated that while Travelan is imported into the U.S. from Australia, it is not a pharmaceutical product but a dietary supplement, and is therefore not expected to be impacted by... 
Via Stocktwits
Topics World Trade
Immuron Letter to Shareholders – Projects Update
From Immuron Limited
Via GlobeNewswire
Immuron partners with InvestorHub
From Immuron Limited
Via GlobeNewswire
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Immuron - FY25 global sales exceed projection, up 49% on prior year
From Immuron Limited
Via GlobeNewswire
Immuron Letter to Shareholders: Projects Update
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Immuron Travelan® highest sales in history
From Immuron Limited
Via GlobeNewswire
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Immuron Announces Travelan® Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
Via ACCESSWIRE
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
From Immuron Limited
Via GlobeNewswire
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
From Immuron Limited
Via GlobeNewswire
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.